* FDA approves TROXYCA ER (oxycodone hydrochloride and
naltrexone hydrochloride) extended-release CAPSULES CII with
abuse-deterrent properties for the management of pain
Source text for Eikon:…
The post BRIEF-FDA approves Pfizer’s TROXYCA ER extended-release capsules CII for pain management appeared first on NASDAQ.